参考文献/References:
[1].专家组,陈韵岱,王建安. 中国冠状动脉血流储备分数测定技术临床路径专家共识[J].中国介入心脏病学杂志,2019,27(3):121-133.
[2].Tonino PA,de Bruyne B,Pijls NH,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. N Engl J Med,2009,360(3):213-224.
[3].de Bruyne B,Pijls NH,Kalesan B,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease[J]. N Engl J Med,2012,367(11):991-1001.
[4].Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes:the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology(ESC)[J]. Eur Heart J,2020,41(3):407-477.
[5].Collet C,Serruys PW. Fractional flow reserve at the crossroad between revascularization and medical therapy[J]. Cardiovasc Diagn Ther,2018,8(4):556-558.
[6].de Bruyne B,Adjedj J. Fractional flow reserve in acute coronary syndromes[J]. Eur Heart J,2015,36(2):75-76.
[7].Smits PC,Laforgia PL,Abdel-Wahab M,et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction:three-year follow-up with cost benefit analysis of the Compare-Acute trial[J]. EuroIntervention,2020,16(3):225-232.
[8].Engstr?m T,Kelb?k H,Helqvist S,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease(DANAMI-3-PRIMULTI):an open-label,randomised controlled trial[J]. Lancet,2015,386(9994):665-671.
[9].陈帅,宁彬. STEMI合并多支血管病变患者首次住院期间完全血运重建对预后的影响[J].中国循证心血管医学杂志,2021,13(9):1118-1120,1123.
[10].[10] Mehta SR,Wood DA,Cairns JA. Complete revascularization with multivessel PCI for myocardial infarction. Reply[J]. N Engl J Med,2020,382(16):1571-1572.
[11].[11] Puymirat E,Cayla G,Simon T,et al. Multivessel PCI guided by FFR or angiography for myocardial infarction[J]. N Engl J Med,2021,385(4):297-308.
[12].[12] Pijls NH,Fearon WF,Tonino PA,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease:2-year follow-up of the FAME(Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study[J]. J Am Coll Cardiol,2010,56(3):177-184.
[13].[13] Layland J,Oldroyd KG,Curzen N,et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction:the British Heart Foundation FAMOUS-NSTEMI randomized trial[J]. Eur Heart J,2015,36(2):100-111.
[14].[14] Tajeddini F,Nikmaneshi MR,Firoozabadi B,et al. High precision invasive FFR,low‐cost invasive iFR,or non‐invasive CFR?:optimum assessment of coronary artery stenosis based on the patient‐specific computational models[J]. Int J Numer Method Biomed Eng,2020,36(10):e3382.
[15].[15] Sen S,Escaned J,Malik IS,et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis:results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study[J]. J Am Coll Cardiol,2012,59(15):1392-1402.
[16].[16] Musto C,de Felice F,Rigattieri S,et al. Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction:the WAVE study[J]. Am Heart J,2017,193:63-69.
[17].[17] Neumann FJ, Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165.
[18].[18] Choi KH,Lee JM,Kim HK,et al. Fractional flow reserve and instantaneous wave-free ratio for nonculprit stenosis in patients with acute myocardial infarction[J]. JACC Cardiovasc Interv,2018,11(18):1848-1858.
[19].[19] G?tberg M,Berntorp K,Rylance R,et al. 5-year outcomes of PCI guided by measurement of instantaneous wave-free ratio versus fractional flow reserve[J]. J Am Coll Cardiol,2022,79(10): 965-974.
[20].[20] Davies JE,Sen S,Dehbi HM,et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI[J]. N Engl J Med,2017,376(19):1824-1834.
[21].[21] Escaned J,Ryan N,Mejía-Rentería H,et al. Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional flow reserve measurements in stable coronary artery disease and acute coronary syndromes[J]. JACC Cardiovasc Interv,2018,11(15):1437-1449.
[22].[22] Mejía‐Rentería H,Lee JM,van der Hoeven NW,et al. Coronary microcirculation downstream non‐infarct‐related arteries in the subacute phase of myocardial infarction:implications for physiology‐guided revascularization[J]. J Am Heart Assoc,2019,8(9):e011534.
[23].[23] Tu S,Westra J,Adjedj J,et al. Fractional flow reserve in clinical practice:from wire-based invasive measurement to image-based computation[J]. Eur Heart J,2020,41(34):3271-3279.
[24].[24] Westra J,Tu S,Campo G,et al. Diagnostic performance of quantitative flow ratio in prospectively enrolled patients:an individual patient‐data meta‐analysis[J]. Catheter Cardiovasc Interv,2019,94(5):693-701.
[25].[25] Westra J,Tu S,Winther S,et al. Evaluation of coronary artery stenosis by quantitative flow ratio during invasive coronary angiography:the WIFIⅡstudy(Wire-Free Functional Imaging Ⅱ)[J]. Circ Cardiovasc Imaging,2018,11(3):e007107.
[26].[26] Xu B,Tu S,Song L,et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVORⅢChina):a multicentre,randomised,sham-controlled trial[J]. Lancet,2021,398(10317):2149-2159.
[27].[27] Erbay A,Penzel L,Abdelwahed YS,et al. Feasibility and diagnostic reliability of quantitative flow ratio in the assessment of non-culprit lesions in acute coronary syndrome[J]. Int J Cardiovasc Imag ing,2021,37(6):1815-1823.
[28].[28] Sejr‐Hansen M,Westra J,Thim T,et al. Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST‐segment elevation myocardial infarction —An iSTEMI substudy[J]. Catheter Cardiovasc Interv,2019,94(5):686-692.
[29].[29] Zhang J,Yao M,Jia X,et al. The efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease:a pilot randomized controlled trial[J]. Cardiol J,2021 Sep 28. DOI:10.5603/CJ.a2021.0111. Online ahead of print.
[30].[30] B?r S,Kavaliauskaite R,Ueki Y,et al. Quantitative flow ratio to predict nontarget vessel-related events at 5 years in patients with ST‐segment-elevation myocardial infarction undergoing angiography‐guided revascularization[J]. J Am Heart Assoc,2021,10(9):e019052.
[31].[31] Ullrich H,Olschewski M,Belhadj KA,et al. Quantitative flow ratio or angiography for the assessment of non-culprit lesions in acute coronary syndromes:protocol of the randomized trial QUOMODO[J]. Front Cardiovasc Med,2022,9:815434.
[32].[32] Taylor CA,Fonte TA,Min JK. Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve:scientific basis[J]. J Am Coll Cardiol,2013,61(22):2233-2241.
[33].[33] Kurata A,Fukuyama N,Hirai K,et al. On-site computed tomography-derived fractional flow reserve using a machine-learning algorithm-clinical effectiveness in a retrospective multicenter cohort[J]. Circ J,2019,83(7):1563-1571.
[34].[34] Ferencik M,Lu MT,Mayrhofer T,et al. Non-invasive fractional flow reserve derived from coronary computed tomography angiography in patients with acute chest pain:subgroup analysis of the ROMICATⅡ trial[J]. J Cardiovasc Comput Tomogr,2019,13(4):196-202.
[35].[35] Chinnaiyan KM,Safian RD,Gallagher ML,et al. Clinical use of CT-derived fractional flow reserve in the emergency department[J]. JACC Cardiovasc Imaging,2020,13(2 Pt 1):452-461.
相似文献/References:
[1]李润土,何泉.光学相干断层成像在急性冠脉综合征介入治疗中的应用[J].心血管病学进展,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
LI Runtu,HE Quan.Application of Optical Coherent Tomography in Interventional Treatment of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(1):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
[2]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(1):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[3]周小琳 何泉.替格瑞洛在急性冠脉综合征合并慢性肾脏病患者中的应用研究进展[J].心血管病学进展,2019,(5):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
ZHOU Xiaolin,HE Quan.Ticagrelor in Acute Coronary Syndrome with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2019,(1):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
[4]刘凡 杨树森.血流储备分数指导冠状动脉再血管化的相关进展[J].心血管病学进展,2019,(5):797.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.033]
LIU FanYANG Shusen.The Relevant Grogress of FFR-Guided Coronary Revascularization[J].Advances in Cardiovascular Diseases,2019,(1):797.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.033]
[5]吕俊兴 许海燕.急性冠脉综合征危险评分的研究进展[J].心血管病学进展,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
LU Junxing,XU Haiyan.Risk Scores of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(1):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
[6]吕颖 胡思宁 于波 贾海波.斑块侵蚀发病机制的最新研究进展[J].心血管病学进展,2020,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
LU Ying,HU Sining,YU Bo,et al.Pathogenic Mechanisms of Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
[7]段继坤,林志,杨帆,等.斑块侵蚀引起的急性冠脉综合征的研究新进展[J].心血管病学进展,2020,(3):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
DUAN Jikun,LIN Zhi,YANG Fan,et al.Acute Coronary Syndrome Caused by Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(1):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
[8]杨金凤,贾辛未,冯惠平,等.血流储备分数用于评估心肌桥及其合并临界狭窄病变的研究现状[J].心血管病学进展,2020,(3):313.[doi:10.16806/j.cnki.issn.1004-3934.20.03.024]
YANG Jinfeng,JIA Xinwei,FENG Huiping,et al.Current Status of Fractional Flow Reserve for Evaluation of Myocardial Bridge and Its Associated Critical Stenosis[J].Advances in Cardiovascular Diseases,2020,(1):313.[doi:10.16806/j.cnki.issn.1004-3934.20.03.024]
[9]杨金凤,贾辛未,唐伟,等.冠状动脉血流储备分数指导下的心肌桥合并近端临界狭窄病变介入治疗疗效观察[J].心血管病学进展,2020,(3):317.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.025]
YANG Jinfeng,JIA Xinwei,TANG Wei,et al.Therapeutic Effect of Percutaneous Coronary Intervention for Myocardial Bridge Combined Proximal Borderline Stenosis under Guidance of Fractional Flow Reserve[J].Advances in Cardiovascular Diseases,2020,(1):317.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.025]
[10]陈凯磊 胡闻竹 苏冠华.P2Y12抑制剂与癌症风险的相关性研究进展[J].心血管病学进展,2020,(8):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
CHEN Kailei,HU Wenzhu,SU Guanhua.Advances in Studies on the Correlation between P2Y12 Inhibitors and Cancer Risk[J].Advances in Cardiovascular Diseases,2020,(1):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]